Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Stem Cell Transcription Factor Sox2 Is Expressed in a Subset of Folliculo-stellate Cells of Growth Hormone–Producing Pituitary Neuroendocrine Tumours and Its Expression Shows No Association with Tumour Size or IGF1 Levels: a Clinicopathological Study of 109 Cases
by
Michalová Květoslava
, Česák Tomáš
, Čáp, Jan
, Soukup Jiri
, Hornychová Helena
, Netuka, David
, Gabalec Filip
, Michnová Ľudmila
in
Acromegaly
/ Growth hormones
/ Insulin-like growth factor I
/ Multivariate analysis
/ Neuroendocrine tumors
/ Phenotypes
/ Pituitary
/ Prolactin
/ S100 protein
/ Stellate cells
/ Stem cells
/ Transcription factors
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Stem Cell Transcription Factor Sox2 Is Expressed in a Subset of Folliculo-stellate Cells of Growth Hormone–Producing Pituitary Neuroendocrine Tumours and Its Expression Shows No Association with Tumour Size or IGF1 Levels: a Clinicopathological Study of 109 Cases
by
Michalová Květoslava
, Česák Tomáš
, Čáp, Jan
, Soukup Jiri
, Hornychová Helena
, Netuka, David
, Gabalec Filip
, Michnová Ľudmila
in
Acromegaly
/ Growth hormones
/ Insulin-like growth factor I
/ Multivariate analysis
/ Neuroendocrine tumors
/ Phenotypes
/ Pituitary
/ Prolactin
/ S100 protein
/ Stellate cells
/ Stem cells
/ Transcription factors
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Stem Cell Transcription Factor Sox2 Is Expressed in a Subset of Folliculo-stellate Cells of Growth Hormone–Producing Pituitary Neuroendocrine Tumours and Its Expression Shows No Association with Tumour Size or IGF1 Levels: a Clinicopathological Study of 109 Cases
by
Michalová Květoslava
, Česák Tomáš
, Čáp, Jan
, Soukup Jiri
, Hornychová Helena
, Netuka, David
, Gabalec Filip
, Michnová Ľudmila
in
Acromegaly
/ Growth hormones
/ Insulin-like growth factor I
/ Multivariate analysis
/ Neuroendocrine tumors
/ Phenotypes
/ Pituitary
/ Prolactin
/ S100 protein
/ Stellate cells
/ Stem cells
/ Transcription factors
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Stem Cell Transcription Factor Sox2 Is Expressed in a Subset of Folliculo-stellate Cells of Growth Hormone–Producing Pituitary Neuroendocrine Tumours and Its Expression Shows No Association with Tumour Size or IGF1 Levels: a Clinicopathological Study of 109 Cases
Journal Article
Stem Cell Transcription Factor Sox2 Is Expressed in a Subset of Folliculo-stellate Cells of Growth Hormone–Producing Pituitary Neuroendocrine Tumours and Its Expression Shows No Association with Tumour Size or IGF1 Levels: a Clinicopathological Study of 109 Cases
2020
Request Book From Autostore
and Choose the Collection Method
Overview
Sox2 is one of the transcription factors responsible for the maintenance of stem cell phenotype. It has been implicated as a marker of stem cells in normal pituitaries and pituitary neuroendocrine tumours. To explore the clinical significance of Sox2 expression in histological sections, we performed immunohistochemical detection of Sox2 in 113 pituitary neuroendocrine tumours from 109 patients with acromegaly. In 11 tumours, we performed double immunostaining for Sox2, annexin A1 and S100 protein. Tumours were characterised using the WHO classification system. Proliferative activity and invasion were assessed. The amount of immunoreactive cells was evaluated and correlated with tumour size and biochemical features (levels of IGF1, GH, prolactin, βTSH). Sox2+ cells were identified in 35/38 normal pituitaries adjacent to the tumours. In 36 tumours (33%), ≥ 1% of the cells expressed Sox2, in 24 cases (22%), Sox2+ cells comprised < 1% and 49 cases (45%) were negative. We found no significant differences between Sox2+ and Sox2− groups with respect to the age, initial levels of GH, IGF1, prolactin, βTSH, tumour size, invasion, proliferative activity or histological features. We observed a positive correlation between Sox2+ cell count and βTSH immunoreactive cells (r = 0.459, p < 0.001) that was further verified by multivariate analysis. Using double stain, the majority of Sox2+ cells coexpressed annexin A1 (average 89%) and S100 protein (average 76.2%) and showed morphological features of folliculo-stellate cells. Sox2+ cells are thus commonly present in growth hormone–producing tumours and normal pituitaries, and their amount does not have any prognostic significance. Most of these cells represent a subpopulation of folliculo-stellate cells, pointing out to their role as a possible stem cell population.
Publisher
Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.